Targeted drug shrinks tumors in 3 out of 4 patients with advanced breast cancer
Top Story
Archived
•
October 29, 2026
•
A phase 3 clinical trial published in JAMA found trastuzumab rezetecan linked to 73% lower risk of cancer progression or death versus chemotherapy.
Source: Fox News Latest | https://feeds.foxnews.com/foxnews/latest - Read Original
Discussion (0)
Please log in to post a comment.
No comments yet. Be the first to share your thoughts!



